Eli Lilly investors shouldn't worry that rival Novo Nordisk has the first anti-obesity pill on sale
Jim Cramer says not to worry about Novo Nordisk's lead over Club that has Eli Lilly in the obesity pill…
health care industry
Shares of Novo Nordisk, maker of Wegovy, rise after approval of GLP-1 pill
Novo Nordisk shares rose more than 7% on Tuesday after the Wegovy maker secured approval for its GLP-1 pill, a…
FDA approves first GLP-1 obesity pill from Wegovy maker Novo Nordisk
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, outside Copenhagen, Denmark, on…
FDA approved work trip to Singapore during government shutdown, records show
SINGAPORE – Sentosa Island features the luxurious five-star Ora and Michael hotels, with palm-fringed pools, lobbies flanked by luxury shops…
Pfizer's 2026 guidance shows deals with Metsera and Seagen will take time to bear fruit
Smith Collection | Stock Photos | fake images Pfizer It forecast modest guidance for 2026 on Tuesday as it looks…
Eli Lilly's Anti-Obesity Pill Maintains Weight Loss After Wegovy, Zepbound
The Eli Lilly & Co. logo at the company's Digital Health Innovation Hub facility in Singapore, Thursday, Nov. 14, 2024.…
How donors, access and polls led Trump to reclassify marijuana
President Donald Trump's decision Thursday to sign an executive order easing federal restrictions on marijuana (and clearing the way for…
UnitedHealth Group Releases Independent Audit Results
A UnitedHealthcare sign is displayed on its office building in Minnetonka, Minnesota, U.S., on Dec. 11, 2025. Tim Evans |…
Trump reclassifies cannabis to Schedule III, easing restrictions on marijuana
US President Donald Trump sits in the Oval Office to sign executive orders, at the White House in Washington, DC,…
Medline Debuts on Nasdaq After Largest IPO of 2025
Shares of the American medical supply giant Medline jumped in its debut on the Nasdaq on Wednesday after the largest…